Share This Page
Drug Price Trends for ZUMANDIMINE
✉ Email this page to a colleague
Average Pharmacy Cost for ZUMANDIMINE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ZUMANDIMINE 3 MG-0.03 MG TAB | 59651-0030-85 | 0.16668 | EACH | 2025-05-21 |
| ZUMANDIMINE 3 MG-0.03 MG TAB | 59651-0030-28 | 0.16668 | EACH | 2025-05-21 |
| ZUMANDIMINE 3 MG-0.03 MG TAB | 59651-0030-85 | 0.18047 | EACH | 2025-04-23 |
| ZUMANDIMINE 3 MG-0.03 MG TAB | 59651-0030-28 | 0.18047 | EACH | 2025-04-23 |
| ZUMANDIMINE 3 MG-0.03 MG TAB | 59651-0030-85 | 0.19107 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Zumandimine
Introduction to Zumandimine
Zumandimine, a combination oral contraceptive containing drospirenone and ethinyl estradiol, is indicated for use by females of reproductive potential to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD), and moderate acne[1][4].
Market Context
The global contraceptive drugs market is experiencing significant growth, projected to increase from USD 18.53 billion in 2023 to USD 40.08 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.02%. This growth is driven by intensified efforts to provide access to contraceptive treatments and a growing focus on family planning due to the rise in unintended pregnancies[3].
Market Segmentation
Product Type
Zumandimine falls under the oral segment of the contraceptive drugs market, which dominates the market with the highest market share. Oral contraceptives, including combination pills like Zumandimine, are preferred due to their ease of use and effectiveness[3].
Distribution Channels
The distribution of Zumandimine and similar contraceptives is widespread across various channels, including hospital pharmacies, retail pharmacies, clinics, online channels, and public health organizations. This broad distribution network contributes to the drug's accessibility and market penetration[3].
Pricing and Cost Considerations
Current Pricing
The cost of Lo-Zumandimine, a generic version of Zumandimine, varies depending on the pharmacy and the quantity purchased. For example, a supply of 84 tablets can cost around $65.80, which translates to approximately $0.78 per unit. Generic versions are available at a lower cost, starting from $28.27 for 28 tablets[2].
Discount Programs and Coupons
To make the drug more affordable, various discount programs and coupons are available. The Drugs.com Discount Card, for instance, can save consumers up to 80% on prescription medicines, including Lo-Zumandimine[2].
Price Projections
Given the growing demand for contraceptive drugs and the expanding market, here are some key points to consider for price projections:
Market Growth
The increasing demand for contraceptive pills, driven by family planning needs and the rise in unintended pregnancies, is expected to sustain the market growth. This demand is likely to keep prices stable or slightly increase them due to higher production costs and market dynamics[3].
Generic Competition
The availability of generic versions of Zumandimine is expected to keep prices competitive. Generic drugs typically offer a more affordable alternative, which can influence the pricing strategy of brand-name drugs[2].
Regulatory and Healthcare Policies
Changes in healthcare policies and formulary updates can impact the pricing and accessibility of drugs like Zumandimine. For example, Medicare Part D plans and other insurance coverage can affect the out-of-pocket costs for consumers[5].
Risks and Considerations
Health Risks
The use of Zumandimine is associated with certain health risks, such as an increased risk of venous thromboembolism (VTE) and serious cardiovascular events, particularly in smokers over 35 years old. These risks can influence prescribing patterns and, consequently, market demand[1][4].
Contraindications
Zumandimine has several contraindications, including renal impairment, adrenal insufficiency, and a high risk of arterial or venous thrombotic diseases. These contraindications can limit the market size and affect pricing due to reduced demand from certain patient groups[1][4].
Key Takeaways
- Market Growth: The global contraceptive drugs market is expected to grow significantly, driven by increased demand for family planning and access to contraceptive treatments.
- Pricing: Current prices for Lo-Zumandimine range from $28.27 to $65.80 depending on the quantity and pharmacy. Discount programs and generic versions help keep costs affordable.
- Price Projections: Prices are likely to remain competitive due to market growth and generic competition. Regulatory policies and healthcare coverage will also influence pricing.
- Health Risks: Associated health risks and contraindications may impact market demand and pricing strategies.
FAQs
Q1: What is Zumandimine used for? Zumandimine is used to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD), and moderate acne in females of reproductive potential[1][4].
Q2: How much does Lo-Zumandimine cost? The cost of Lo-Zumandimine can range from $28.27 for 28 tablets to $65.80 for 84 tablets, depending on the pharmacy and quantity[2].
Q3: Are there any health risks associated with Zumandimine? Yes, Zumandimine is associated with an increased risk of venous thromboembolism (VTE) and serious cardiovascular events, particularly in smokers over 35 years old[1][4].
Q4: What are the contraindications for Zumandimine? Zumandimine is contraindicated in patients with renal impairment, adrenal insufficiency, high risk of arterial or venous thrombotic diseases, undiagnosed abnormal uterine bleeding, breast cancer, liver tumors or liver disease, and co-administration with certain Hepatitis C drug combinations[1][4].
Q5: How does the availability of generic versions affect the pricing of Zumandimine? The availability of generic versions helps keep the prices of Zumandimine competitive, offering consumers a more affordable alternative[2].
Sources
- Drugs.com: Zumandimine Package Insert / Prescribing Information.
- Drugs.com: Lo-Zumandimine Prices, Coupons, Copay Cards & Patient Assistance.
- GlobeNewswire: Global Contraceptive Drugs Market Size To Worth USD 40.08 Billion By 2033.
- Drugs.com: Lo-Zumandimine Package Insert / Prescribing Information.
- Delaware Health and Social Services: 2025 Formulary.
More… ↓
